Upgrade to SI Premium - Free Trial

Lipocine (LPCN)

2.27 +0.02 (0.89%)

Chart
Today 6M 1Y 5Y

Upcoming Events

- Earnings (11/11/26)

Latest Headlines

Form 8-K Lipocine Inc. For: Sep 08 September 11, 2026 6:11 AM - SEC Filing Lipocine to Present at the H.C. Wainwright 28th Annual Global Investment Conference September 10, 2026 8:00 AM - PR NewsWire Form 8-K Lipocine Inc. For: Sep 10 September 10, 2026 6:14 AM - SEC Filing Form 8-K/A Lipocine Inc. For: Aug 03 August 21, 2026 4:30 PM - SEC Filing Form SCHEDULE 13G/A Lipocine Inc. Filed by: Squadron Capital Management LLC August 14, 2026 1:02 PM - SEC Filing Form 4 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael August 7, 2026 4:12 PM - SEC Filing Form 3 Lipocine Inc. For: Aug 03 Filed by: Grissinger Michael August 7, 2026 4:08 PM - SEC Filing Lipocine (LPCN) Tops Q2 EPS by 12c August 4, 2026 4:48 PM - StreetInsider Lipocine Announces Financial Results for the Second Quarter Ended June 30, 2026 August 4, 2026 8:00 AM - PR NewsWire Form 8-K Lipocine Inc. For: Aug 04 August 4, 2026 6:09 AM - SEC Filing Form 10-Q Lipocine Inc. For: Jun 30 August 4, 2026 6:05 AM - SEC Filing Form 8-K Lipocine Inc. For: Aug 03 August 3, 2026 9:35 AM - SEC Filing Lipocine names former Johnson & Johnson executive to its board August 3, 2026 8:00 AM - StreetInsider Lipocine Appoints Michael J. Grissinger to Board of Directors August 3, 2026 8:00 AM - PR NewsWire Form 4 Lipocine Inc. For: Jun 29 Filed by: Patel Mahesh V. June 30, 2026 7:31 PM - SEC Filing Full Article List